VVUS: Icahnic Move or a Blip on the Radar?
Vivus has a 52 week high/low band of $4.82-$0.94. Since its public inception in 1994, this range is $39.50-$0.94. Ouch. That’s an 83% decline. However, early investors, whom saw a peak of almost $40 in 1997, from an average of $8 per share the two years prior, had a spectacular opportunity. Following that run-up the stock languished in a range of between seven and ten dollars till 2009, which was then followed by a second, but lower peak back up to $29 in 2012. Since then, and till August of this year, a miserably steady, prominent, and unnerving spiral downwards has taken a nasty grip and toll on this company. This is an opportunity to be in possession of shares that are to be snapped-up at collection agency prices, with but only $1.40/share to lose at the upper most end of your money. Or a foolish errand that will have one chalking this up to yet another bad dream of unfulfilled, skyrocket moves in the stock market. “Hey, even if it only goes back up to two or three dollars, there’s some serious money to be made here.” “Pharmaceuticals are the future, especially with the over 85 age group growing exponentially.” “Why not take a chance on this stock? It’s dirt cheap, and Carl Icahn wants in!” Positive sentiments abound. But also remember that stocks are often priced at one or two dollars a share for a very good reason: That’s what their true value actually is. And to break below a dollar per share, psychologically, is a major game-changer. It’s a permanent scar that certain investors are unable to forgive or forget.
Charts don’t lie. And if we look at VVUS today, this is the situation: Chart-wise, VVUS could not be at a more prescient or pivotal moment than at this most recent price level. Something big is definitely in the offing, as this stock is very unlikely to remain in the $1-2 range for a long period of time. It is desperately, while somewhat convincingly and successfully, so far, attempting to install a floor of comfort and stability here. The next key area is $1.70-$1.75, and if it reaches and surpasses that threshold, an expectation of two dollars per share would not be unreasonable, but warranted and deserved. The stock has a beta of over 2, so volatility is a very welcome guest here, as there is plenty of room to the previous upside. Conversely, if VVUS breaks below $1 again, then this was all a masquerade.
One must wonder what Mr. Icahn is up to, and where/what/whom his confidence is derived from. Why this esoteric arrangement rather than an outright stake in the company? He probably knows all too well about cheap stocks and their promises, promises, promises. Still, he is no fool. Let’s face it, nobody wants to be obese and obtain other negative health results associated with that condition, or have erectile dysfunction. But ‘diet pills’ have been tried for years, with minor results. And STENDRA is not yet a household name, so their marketing team needs to be ready to pounce on Viagra, as it is fast becoming a lexicon for sexual performance.
Finally, PredictWallStreet.com, where investors and traders can offer their opinions on the direction of a particular stock, has an 80% positive performance expectation on VVUS, vs a 20% negative one. The past accuracy rate of these opinionated individuals though, is 38%. Crowds can be maddeningly wrong at times, but sometimes that ship of gold does arrive, and VVUS is a viable candidate for further good fortune. But this is a stock you’ll have to babysit, each and every trading day, if you wish to participate and/or at least hold on to most of your investment. Dismiss that notion of ‘buy it and forget it’. And please engrave it, somewhere where you look often, that this child is not to be left unattended. So keep a keen eye open over the next few days. Short sellers hold 35% of shares outstanding. Good Tidings.
Disclaimer
Our reports/releases are a commercial advertisement and are for general information purposes only. We are engaged in the business of marketing and advertising companies for monetary compensation. Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. The disclaimer is to be read and fully understood before using our services, joining our site or our email/blog list as well as any social networking platforms we may use. Broadstreetalerts.com has not been compensated in any form by any entity for information shared on this page.
PLEASE NOTE: Broadstreetalerts.com and its employees are not a Registered Investment Advisor, Broker Dealer or a member of any association for other research providers in any jurisdiction whatsoever.
Release of Liability: Through use of this website viewing or using you agree to hold Broadstreetalerts.com, its operators owners and employees harmless and to completely release them from any and all liability due to any and all loss (monetary or otherwise), damage (monetary or otherwise), or injury (monetary or otherwise) that you may incur. The information contained herein is based on sources which we believe to be reliable but is not guaranteed by us as being accurate and does not purport to be a complete statement or summary of the available data. Broadstreetalerts.com encourages readers and investors to supplement the information in these reports with independent research and other professional advice. All information on featured companies is provided by the companies profiled, or is available from public sources and Broadstreetalerts.com makes no representations, warranties or guarantees as to the accuracy or completeness of the disclosure by the profiled companies. None of the materials or advertisements herein constitute offers or solicitations to purchase or sell securities of the companies profiled herein and any decision to invest in any such company or other financial decisions should not be made based upon the information provide herein. Instead Broadstreetalerts.com strongly urges you conduct a complete and independent investigation of the respective companies and consideration of all pertinent risks. Readers are advised to review SEC periodic reports: Forms 10-Q, 10K, Form 8-K, insider reports, Forms 3, 4, 5 Schedule 13D. Broadstreetalerts.com is compliant with the Can Spam Act of 2003. Broadstreetalerts.com does not offer such advice or analysis, and Broadstreetalerts.com further urges you to consult your own independent tax, business, financial and investment advisors. Investing in micro-cap and growth securities is highly speculative and carries and extremely high degree of risk. It is possible that an investor’s investment may be lost or impaired due to the speculative nature of the companies profiled.
The Private Securities Litigation Reform Act of 1995 provides investors a ‘safe harbor’ in regard to forward-looking statements. Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, goals, assumptions or future events or performance are not statements of historical fact may be “forward looking statements”. Forward looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements in this action may be identified through use of words such as “projects”, “foresee”, “expects”, “will”, “anticipates”, “estimates”, “believes”, “understands”, or that by statements indicating certain actions & quote; “may”, “could”, or “might” occur. Understand there is no guarantee past performance will be indicative of future results.
In preparing this publication, Broadstreetalerts.com has relied upon information supplied by its customers, publicly available information and press releases which it believes to be reliable; however, such reliability cannot be guaranteed. Investors should not rely on the information contained in this website. Rather, investors should use the information contained in this website as a starting point for doing additional independent research on the featured companies. The advertisements in this website are believed to be reliable, however, Broadstreetalerts.com com and its owners, affiliates, subsidiaries, officers, directors, representatives and agents disclaim any liability as to the completeness or accuracy of the information contained in any advertisement and for any omissions of materials facts from such advertisement. Broadstreetalerts.com is not responsible for any claims made by the companies advertised herein, nor is Broadstreetalerts.com responsible for any other promotional firm, its program or its structure.
Broadstreetalerts.com